Showing results (231-240 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|May 8, 2023
The prevalence of moderate-severe premenstrual syndrome and premenstrual dysphoric disorder and the related factors in high school students: A cross-sectional studyFarzaneh Babapour, Forouzan Elyasi, Zohreh Shahhosseini, et al.
Neuropsychopharmacology Reports|August 12, 2022
Caffeine facilitates extinction of auditory fear conditioning in ratsTakaaki Ozawa, Kodai Kaseda, Yukio Ichitani, et al.
Neuropsychopharmacology Reports|February 22, 2023
Management of unspecified anxiety disorder: Expert consensusHitoshi Sakurai, Ken Inada, Yumi Aoki, et al.
Neuropsychopharmacology Reports|May 27, 2020
Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefectureTatsuichiro Takahashi, Tetsuya Otsubo, Susumu Kunisawa, et al.
Neuropsychopharmacology Reports|May 14, 2021
An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patientsSimon Erridge, Oliver Salazar, Michal Kawka, et al.
Neuropsychopharmacology Reports|August 6, 2021
Transient glyphosate encephalopathy due to a suicide attemptSaaya Yokoyama, Tomomi Sugisaki, Yoshida Ryota, et al.
Neuropsychopharmacology Reports|August 6, 2021
Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case reportShintaro Sakai, Yoshiro Morimoto, Yusuke Matsuzaka, et al.
Neuropsychopharmacology Reports|February 27, 2023
Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX-2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesisToshinori Shirata, Shinji Yano, Keisuke Noto, et al.
Neuropsychopharmacology Reports|March 14, 2023
Factors influencing postpartum depression among Japanese parents: A prospective longitudinal studyYuko Yamakawa, Michio Maruta, Yuya Higuchi, et al.
Neuropsychopharmacology Reports|November 17, 2022
Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood DisordersKentaro Fukumoto, Fumitoshi Kodaka, Naomi Hasegawa, et al.
Pageof 66